Studies of neonatal neural pathologies and development of appropriate therapeutics are hampered by a lack of relevant in vitro models of neonatal blood-brain barrier (BBB). To establish such a model, we have developed a novel blood-brain barrier on a chip (B 3 C) that comprises a tissue compartment and vascular channels placed side-by-side mimicking the three-dimensional morphology, size and flow characteristics of microvessels in vivo. C allowed endfeet-like astrocyte-endothelial cell interactions through a porous interface that separates the tissue compartment containing cultured astrocytes from the cultured RBEC in the vascular channels. The permeability of fluorescent 40 kDa dextran from vascular channel to the tissue compartment significantly decreased when RBEC were cultured in the presence of astrocytes or ACM (from 41.0±0.9 x 10 −6 cm/s to 2.9±1.0 x 10 −6 cm/s or 1.1±0.4 x 10 −6 cm/s, respectively). Measurement of electrical resistance in B 3 C further supports that the addition of ACM significantly improves the barrier function in neonatal RBEC. Moreover, B 3 C exhibits significantly improved barrier characteristics compared to the transwell model and B 3 C permeability was not significantly different from the in vivo BBB permeability in neonatal rats. In summary, we developed a first dynamic in vitro neonatal BBB on a chip (B 3 C) that closely mimics the in vivo microenvironment, offers the flexibility of real time analysis, and is suitable for studies of BBB function as well as screening of novel therapeutics.
comprises a tissue compartment and vascular channels placed side-by-side mimicking the three-dimensional morphology, size and flow characteristics of microvessels in vivo. Rat brain endothelial cells (RBEC) isolated from neonatal rats were seeded in the vascular channels of B 3 C and maintained under shear flow conditions, while neonatal rat astrocytes were cultured under static conditions in the tissue compartment of the B 3 C. RBEC formed continuous endothelial lining with a central lumen along the length of the vascular channels of B 3 C and exhibited tight junction formation, as measured by the expression of zonula occludens-1 (ZO-1). ZO-1 expression significantly increased with shear flow in the vascular channels and with the presence of astrocyte conditioned medium (ACM) or astrocytes cultured in the tissue compartment. Consistent with in vivo BBB, B 3 C allowed endfeet-like astrocyte-endothelial cell interactions through a porous interface that separates the tissue compartment containing cultured astrocytes from the cultured RBEC in the vascular channels. The permeability of fluorescent 40 kDa dextran from vascular channel to the tissue compartment significantly decreased when RBEC were cultured in the presence of astrocytes or ACM (from 41.0±0.9 x 10 −6 cm/s to 2.9±1.0 x 10 −6 cm/s or 1.1±0.4 x 10 −6 cm/s, respectively). Measurement of electrical resistance in B 3 C further supports that the addition of ACM significantly improves the barrier function in neonatal RBEC. Moreover, B 3 C exhibits significantly improved barrier characteristics compared to the transwell model and B 3 C permeability was not significantly different from the in vivo BBB permeability in neonatal rats. In summary, we developed a first dynamic in vitro neonatal BBB on a chip (B 3 C) that closely mimics the in vivo microenvironment, offers the flexibility of real time analysis, and is suitable for studies of BBB function as well as screening of novel therapeutics.
Introduction
Blood-brain barrier (BBB) is a physical and functional barrier formed by the brain vascular endothelial cells and perivascular cells [1, 2] . It is highly effective and selective to the passage of molecules from the blood to the brain tissue, and is important for the maintenance of normal function of the brain in adults and neonates [3] [4] [5] [6] [7] . Although the significance of the BBB in the initiation and progression of neonatal neural pathologies, e.g. neurodevelopmental injuries, has been recognized, research in this area has been hampered by a lack of relevant in vitro models of neonatal BBB [8] . Small animal models often used to study the permeability across BBB have the advantage of studying the brain in its natural environment [9] [10] [11] . However, such in vivo studies are expensive, lengthy and difficult to perform especially in neonatal animals. Therefore, there has been a long-standing interest in the development of in vitro BBB models that could mimic the neonatal in vivo BBB microenvironment. Traditional in vitro BBB models use static cell-based assays in a transwell type apparatus to measure permeability of various tracers which provide suitable models for both drug permeability studies and physiological and pathological experiments [12, 13] . Transwell based BBB models have also been improved to approximate several important aspects of the in vivo BBB including high electrical resistance and realistic cytoarchitecture [12] [13] [14] [15] [16] . Nevertheless, these in vitro BBB models often lack realistic morphological (e.g. realistic microvascular size and tube-like structure of vascular channels) and functional (e.g. physiological shear flow in the vascular compartment) features that allow for the development of a realistic in vivo-like microenvironment. Furthermore, two-dimensional monocultures of primary adult endothelial cells used in simple BBB in vitro models over time lose many of the characteristics of the in vivo phenotype, e.g. tight junction formation. These observations suggest that a proper microenvironment such as factors secreted by the perivascular cells and/or realistic shear forces from blood flow is required to maintain an optimally functioning neonatal in vitro BBB.
More recently, newer in vitro BBB models have been developed that attempt to incorporate some of the important features of the in vivo brain microenvironment. These two dimensional models are developed using either a monoculture of adult endothelial cells, co-culture of endothelial cells with glial cells, or the factors secreted by the glial cells in either a static or a dynamic flow based configuration [17] [18] [19] [20] [21] [22] [23] . Of these, the DIV-BBB and NDIV-BBB models developed by Cucullo et al. represent a new class of dynamic in vitro BBB models that incorporate shear flow in addition to the presence of glial cells. However, these devices use large fiber diameter (>600 μm) which necessitates unrealistically high flow rates to maintain physiological shear and alters the balance of convective and diffusive transport. The larger size of the device also leads to larger requirement of consumables. To minimize the large volumes of samples, researchers have adapted to microfluidics based approaches for development of the BBB model [24, 25] . However, these microfluidic models still employ transwell membranes that do not allow real-time visualization of the BBB function and lack realistic microvascular geometries. Furthermore, neonatal and adult BBB have been found to exhibit significant differences in terms of their structure and function, thus neonatal endothelial and perivascular cells are required to accurately represent the neonatal BBB [26] [27] [28] [29] [30] . In a recent study a transwell based static in vitro model of a neonatal BBB was developed for the first time [31] . Although this study used brain capillary endothelial cells isolated from neonatal rat brain, this model still lacks the shear flow and the realistic three-dimensional microvascular geometry that are essential for a dynamic, physiologically realistic in vitro BBB model.
To overcome the above mentioned limitations, in a previous study, our group developed a framework for a microfluidic model of the BBB using a well characterized adult rat endothelial cell line (RBE4) [32] . In the present study, we report on the development of a novel dynamic neonatal blood-brain barrier on a chip (B 3 C) constructed with a tissue compartment and microvascular channels that mimic the three-dimensional morphology, size, and flow characteristics of microvessels in vivo. For the first time, B 3 C allows for the co-culture of primary neonatal brain endothelial cells and astrocytes in communication through porous interface, leading to a realistically tight barrier, which mimics the neonatal in vivo BBB. The side-by-side placement of optically clear vascular channels and the tissue compartment in B 3 C allows for real-time visualization and direct measurement of the dynamic processes taking place within the neonatal BBB which is a significant advantage when compared with transwell or other membrane based in vitro models of the BBB.
Materials and Methods Materials
Endothelial basal medium-2 (EBM-2) and Astrocyte Growth Medium (AGM) bullet kit were from Lonza Inc., Walkersville MD. 
Fabrication of B 3 C
To fabricate the microfluidic neonatal BBB on a chip (B 3 C), a photomask of the design shown in Fig 1A was created and soft photolithography was used to fabricate the final B 3 C model shown in Fig 1C on a microscope slide as described previously [32] . Briefly, Sylgard 184 Polydimethylsiloxane (PDMS) was prepared according to manufacturer's (Dow Corning, Midland, MI) instructions and was poured over the developed master in a 150 mm Petri dish which was degassed for 15 min. The polymer was then allowed to cure overnight in an oven at 65°C. Inlet and outlet holes were punched using a 1.5 mm punch. The bonding surfaces of the PDMS and glass slide were plasma treated in a plasma generator (Harrick Scientific, Ithaca, NY). The assembly was heated at 75°C for 10 min to achieve a seal between the PDMS and glass yielding the complete device. The resulting B 3 C comprises of a disposable optically clear polydimethylsiloxane (PDMS) microfluidic chip containing a tissue and vascular channels [32, 33] . The size of the vascular channel is in the range of diameters observed in neonatal rats evaluated using a cranial window model and fluorescence microscopy [11] .
Cell Cultures
All experiments involving animals were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of Temple University (Permit Number: 4179). All efforts were made to minimize suffering. Sprague-Dawley (SD) rats were obtained from Taconic Farms (Hudson, NY). Primary cultures of neonatal rat brain capillary endothelial cells (RBEC) were obtained from two week old SD rats of either sex, with a modification of previously described protocols [31] . Rats were euthanized by CO 2 followed by decapitation; brains were removed and placed in ice-cold phosphate-buffered saline (PBS). After removing the meninges, the cortices were minced into small pieces, gently dissociated by pipetting and digested in a mixture of collagenase/dispase (270 U/mL and 0.1%, respectively, GibcoBRL) and DNAse (10 U/mL, Sigma-Aldrich) in DMEM for 1.5 H at 37°C. After digestion, the microvessels were separated by centrifugation in 20% bovine serum albumin (BSA) in DMEM (1000 x g for 15 min). The microvessels obtained in the pellet were further digested in collagenase/dispase mixture for 1 H at 37°C. Capillary fragments were isolated by filtering through 10 μm nylon filter before plating on collagen type IV coated dishes (5 μg/cm 2 , Sigma-Aldrich). RBEC cultures were maintained in endothelial cell basal medium (Lonza Inc.) supplemented with 20% Bovine plasma-derived serum (BPDS), penicillin and streptomycin 100 U/mL & 100 μg/ml respectively (Mediatech Inc.) containing puromycin (4 μg/ml, Sigma-Aldrich) (allows selective growth of endothelial cells) and cultured for two days [34] . To remove the puromycin, cells were washed 3 times with fresh endothelial cell basal medium and cultured in endothelial cell basal medium (Lonza Inc.) supplemented with 20% Bovine plasma-derived serum, 100 μg/mL penicillin/streptomycin (Mediatech Inc.) containing basic Fibroblast Growth Factor (2 ng/mL; human recombinant; Invitrogen) and hydrocortisone (500 ng/mL; Sigma-Aldrich) until 80% -90% confluent. For subsequent RBEC culture, cells were cultured in flasks coated with rat collagen type I (5 μg/cm 2 ). Cells from passage 3 were used in experiments.
Primary cultures of neonatal rat astrocytes were obtained from the cerebral cortex of two week old SD rats according to previously described methods [31] . In brief, after removing the meninges and blood vessels, the forebrains were minced and gently dissociated by repeated pipetting in DMEM containing 10% fetal bovine serum (FBS) (Atlanta Biologicals) and 100 μg/ mL penicillin/streptomycin (Mediatech Inc.) and filtered through 70 μm cell strainer. After centrifugation, cells were re-suspended in DMEM containing 10% FBS and cultured in 75 cm 2 tissue culture flasks at 37°C. Cell medium was changed every 2-3 days. The non-adherent cells were removed after 10-14 days in culture by vigorous shaking of the flask and the adherent astrocytes were thoroughly washed with PBS, trypsynized and seeded into new culture flasks. The purity of astrocytes (from passage 2) was confirmed using immunostaining for GFAP (an astrocytic marker) and CD11b (microglial cell marker) as shown in S4 Fig Inc.), subconfluent growing cells were collected by washing the cells with PBS, centrifuged and then dissociated with trypsin followed by inactivation with medium containing serum. Cells from passage 2 were used in experiments. For collection of astrocyte conditioned medium (ACM), neonatal rat astrocytes were cultured in astrocyte growth medium (AGM, Lonza Inc.) in T75 tissue culture flasks (Thermo Fisher Scientific Inc.) until reaching 95-100% confluence. Then, the medium was replaced with RBEC medium containing 2% BPDS. The cells were incubated in RBEC medium for 48 hours and then ACM was collected, filtered using 0.2 μm syringe filter (Millipore, SLMP025SS) and stored at -20°C until used in experiments. For all experiments using ACM, a 50:50 volume mixture of ACM and RBEC medium was used.
Adult rat brain endothelial cells (adult RBEC) isolated from 8-10 week old Sprague Dawley rats were purchased from Cell Applications, San Diego CA.
RBEC and Astrocyte Culture in B 3 C
Prior to endothelial cell seeding, vascular channels of B 3 C were coated with rat fibronectin (40 μg/cm 2 , EMD Millipore) at 4°C overnight. RBEC at a concentration of 3-5x10 7 cells/ml of RBEC medium were seeded at a flow rate of 10 μl/min in the fibronectin coated vascular channels using a syringe mounted on a programmable PHD Ultra syringe pump (Harvard Apparatus, Holliston MA). The B 3 C inlets were clamped when the RBEC reached a density of 80-90% in the vascular channels and the B 3 C was transferred to a CO 2 incubator at 37°C to allow the cells to attach in the absence of flow. After 4-5 hours of incubation, the medium in the vascular channels was replaced with fresh RBEC medium or RBEC medium containing 50% ACM and flow was started at a rate of 0.01 μl/min (i.e. shear stress of 3.8x10 −3 dynes/cm 2 ) using syringes mounted on a PHD Ultra syringe pump placed adjacent to the incubator. B 3 C was connected to these syringes using Tygon tubing (Saint Gobain, USA; Cat. No. AAD04103), where~75% of the total tube length of 12-18 inches resides inside the incubator thus warming up the media to 37°C before entering the B 3 C. Flow in the vascular channels was maintained for 5 days while syringes containing old medium were replaced with syringes containing fresh medium every 2-3 days. At the end of 5 days, cells in the vascular channels were either fixed with methanol or paraformaldehyde for immunofluorescence staining or the permeability was measured in cultured cells as described below.
For co-culture of RBEC with rat astrocytes, the vascular channels and the tissue compartment were coated with rat fibronectin (40 μg/cm 2 and 20 μg/cm 2 , respectively, EMD Millipore). The device was kept at 4°C overnight before cell seeding was carried out. Prior to cell seeding the B 3 C was brought to room temperature and vascular channels were filled with AGM containing 20% FBS and the device was transferred to the CO 2 incubator at 37°C. Subsequently, rat astrocytes from confluent cultures were harvested using TrypLE Select (Life Technologies Corp.) and resuspended in AGM containing 20% FBS at a concentration of 1.5-2.0x10 7 cells/ml. This cell suspension was injected into the tissue compartment of B 3 C at a flow rate of 10 μl/min using a syringe mounted on a programmable PHD Ultra syringe pump (Harvard Apparatus, Holliston MA) as described above. When astrocytes in the tissue compartment reached a cell density of 50-60%, the access to the tissue compartment was closed and the device was returned to the CO 2 incubator at 37°C for overnight incubation. On the next day, the vascular channels were coated again with rat fibronectin (40 μg/cm 2 , EMD Millipore) and maintained for about an hour at 37°C prior to seeding. Next, the medium in the entire device was replaced with RBEC medium containing 20% FBS and RBEC were seeded onto fibronection coated inner surface of vascular channels as described above. RBEC medium was flowed over RBEC cultured in vascular channels at a flow rate of 0.01 μl/min (i.e. shear stress of 3.8x10 -3 dynes/cm 2 ) and the astrocytes in the tissue compartment were maintained under static conditions in RBEC medium. The syringes were covered with aluminium foil to avoid exposure of the medium to the light.
Measurement of Permeability and Electrical Resistance in B 3 C
For permeability measurements, B 3 C was mounted on a fluorescence microscope (Nikon TE200) equipped with an automated stage, and images were acquired using ORCA Flash 4 camera (Hamamatsu Corp., USA). Prior to the analysis of permeability, the vascular channel was connected to a Hamilton gas tight syringe filled with Texas Red 40 kDa dextran (25 μM in RBEC culture medium) mounted on a syringe pump (PhD Ultra Syringe pump, Harvard Apparatus). A syringe warmer was used to keep the culture medium in B 3 C at a physiological temperature. Nikon's NIS Elements software (Nikon Instruments Inc., Melville, NY) was used to control the microscope stage and the camera settings. The permeability was measured in B C is made from an optically clear PDMS, which is assembled on a microscope slide to monitor the passage of fluorescent 40 kDa dextran from vascular channels to the tissue compartment over time. Permeation of 40 kDa dextran across the BBB in B 3 C was analyzed offline using NIS Elements imaging software. Using our previously reported methods [11] , we used the following equation to calculate permeability (P) of dextran across BBB in B 3 C:
where I t is the average intensity in the tissue compartment, I v0 is the maximum fluorescence intensity of the vascular channel, V/S is the ratio of vascular channel volume to its surface area. The permeability of an empty device was subtracted from the total apparent permeability to obtain the actual permeability of RBEC under different conditions; following Eq 2 was used for this calculation.
For electrical resistance measurements in B 3 C, an electrode compartment was created outside the vascular channel. Barrier resistance was determined using a 2-point measurement system. Ag/AgCl electrodes were inserted into the tissue compartment and the electrode compartment and connected to SynVivo Cell Resistance Analyzer (CFD Research Corporation, Huntsville AL). These electrodes were then used to apply a constant 200 mV sinusoidal voltage signal at 1 kHz and the resulting current was used to calculate the resistance. Resistance of cellfree B 3 C (control) or B 3 C with RBEC or RBEC + ACM was measured every day for up to six days after seeding of the cells.
Measurement of Permeability and Electrical Resistance in Transwell Model
Transwell based BBB models have been used extensively to study the BBB. Thus, we compared the performance of B 3 C to the transwell BBB model using neonatal RBEC. Transwell inserts (polyester membrane 12-well plate transwell, membrane pore size = 3 μm, membrane surface area = 1.12 cm 2 , Corning Inc., Lowell, MA) were coated with rat fibronectin (5 μg/cm 2 , EMD Millipore) overnight at 4°C. The next day, RBEC from a confluent culture were harvested and seeded at a density of 175,000-200,000 cells/well (150,000-180,000 cells/cm 2 ) on the apical side of the transwell inserts using RBEC medium containing 20% BPDS [31] . After overnight incubation in the CO 2 incubator at 37°C, the medium was replaced with fresh RBEC medium or RBEC medium containing 50% ACM. Medium in the transwells was replaced with fresh medium every 2-3 days. These cultures were maintained for 5 days before used for permeability measurements. For measuring permeability of transwell BBB, Texas-Red 40 kDa dextran (25 μM in RBEC medium) was added to the apical side of the transwell. At fixed time intervals, 50 μl of sample was collected from the basolateral side, which was replaced by 50 μl fresh RBEC medium to avoid volume dependent concentration gradients. A plate reader (Tecan Infinite 200 Pro) was used to measure the fluorescence level of collected samples from the basolateral compartment over time and to calculate its permeability using Eqs 1 and 2 above. Electrical resistance measurements in transwell were carried out using EVOM2 TEER instrument with STX2 chopstick electrodes (World Precision Instruments, Sarasota, FL). Resistance of cell-free transwell (control) or transwell with RBEC or RBEC + ACM was measured every day for up to six days after seeding of the cells.
Immunocytochemistry
For immunocytochemistry of tight junction protein ZO-1, astrocytic marker GFAP and microglial marker CD11b, cells were fixed in ice cold methanol at -20°C (for ZO-1 staining) or in 4% paraformaldehyde at room temperature (for GFAP and CD11b double immunostaining) for 10 min [13] , permeabilized with 0.1% Triton X-100 for 10 min (only for GFAP) at room temperature and subsequently blocked with 10% goat serum in 1X PBS for one hour at room temperature. For the detection of tight junction protein, ZO-1 in RBEC, a rabbit polyclonal antibody to ZO-1 was used (1:100 dilution). For the detection of GFAP expression in astrocytes, a polyclonal rabbit antibody to GFAP was used (1:250 dilution). The fixed cells were incubated with primary antibodies at 4°C overnight followed by species-specific AlexaFluor 488 or AlexaFluor 594 secondary antibody (1:1000 dilution) for one hour at room temperature in the dark. Nuclei were counterstained using Hoechst 33342 nuclear stain in PBS at 37°C for 10-15 min. Cells were examined using a Nikon TE200 fluorescence microscope using Nikon's NIS elements software.
For confocal imaging of filamentous-actin in RBEC, cells were fixed in 4% paraformaldehyde at room temperature for 10 min followed by permeabilization with 0.1% Triton X-100 for 10 min at room temperature. Alexa 
Measurement of Permeability across In Vivo BBB in Neonatal Rat
All procedures involving animals were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of Temple University (Permit Number: 4179). All efforts were made to minimize suffering. Sprague Dawley (SD) rats were obtained from Taconic Farms (Hudson, NY). In vivo BBB permeability of fluorescein isothiocyanate (FITC) conjugated 40 kDa dextran (Sigma-Aldrich) was measured in two week old SD rats using our previously described protocol [11] . Briefly, animals were anesthetized with an intraperitoneal (i.p.) injection of a solution of ketamine (87 mg/ml) and xylazine (13 mg/ml) at an appropriate dose (0.5 ml/kg body weight) and a cranial window was created as described previously [11] . The fluorescent dextran (50 mg/ ml, 1 ml /kg body weight) was injected into the jugular vein through a cannula. The intensity of the fluorescent dextran was measured (Rollera Bolt fluorescence camera from QImaging, Surrey, BC, Canada) in the vessels and brain tissue for 5 seconds every minute and was used to estimate permeability of 40 kDa dextran. At the end of the experiment, the animals were euthanized by overdose of pentobarbitol and then exsanguination.
Statistical Analysis
A paired student's t-test was used for comparing two means for the effect of a treatment. Oneway ANOVA was used for comparing more than two means with single factor and Tukey's multiple comparison test was used for comparing multiple means. Two-factor ANOVA was used for determining the effect of two independent factors and Tukey's multiple comparison test was used for comparing multiple means. Statistical analyses were performed using SigmaPlot 12.3 (San Jose, CA) and p<0.05 was considered significant.
Results

Development of a Fluorescence Microscopy Based Method for Measuring Permeability in B 3 C
A photomask was used to construct B 3 C with two independent vascular channels with dimensions of 200 μm x 100 μm x 2762 μm (width x height x length) placed around the tissue compartment ( Fig 1A) . The 3D geometry of vascular channels and dimensions that closely approximate the size and morphology of microvessels in vivo permit the B 3 C model to maintain shear flow conditions in vascular channels. As shown in Fig 1A and 1B , the side-by-side placement of optically clear vascular channels and the tissue compartment in B 3 C permits simultaneous real-time visualization of both compartments. The porous interface allows for biochemical and cellular communication between the two compartments. As schematically shown in Fig 1B, device is constructed from optically clear PDMS assembled on a microscope slide as shown in Fig 1C. Since the B 3 C developed here is a dynamic in vitro model of neonatal BBB suitable for realtime monitoring and direct measurement of permeability across BBB using microscopic methods, we first optimized the techniques for quantifying permeability in B 3 C. Permeation of the fluorescent 40 kDa dextran from the vascular channel to the tissue compartment of cell-free B 3 C was characterized by imaging over time as dextran was injected into the vascular channel at a flow rate of 0.2 μl/min (i.e. shear stress of 7.6x10 -2 dynes/cm 2 ). As shown in Fig 2A, 2B , 2C, 2D and 2E, fluorescent dextran accumulates in the tissue compartment in a time-dependent manner over a 120 min period. Quantification of permeability was performed by calculating the average intensity of fluorescent dextran in the entire tissue compartment and normalizing it to the maximum intensity of fluorescent dextran in the vascular channel. The results of a typical cell-free experiment shown in Fig 2F indicate that the normalized intensity increases linearly with time in the tissue compartment. The slope of the line (dI t /dt) in Fig 2F is used to calculate the permeability of dextran from the vascular channel to the tissue compartment using Eq 1, which gives (P) Cell-Free (in this case 10 x 10 −6 cm/s) used in Eq 2.
Neonatal RBEC form a Complete Lumen along the Walls of the Vascular Channel and Exhibit Increased Expression of Tight Junctions in B 3 C
RBEC (from passage 3) were seeded on a fibronection coated inner surface of vascular channels of B 3 C and maintained under a flow rate of 0.01 μl/min (i.e. shear stress of 3.8x10 Endothelial cells exhibit barrier formation by expressing tight junction proteins (e.g. ZO-1) that are an integral part of the tight junction complexes at the cell-cell contact that make up the BBB [27] . The ZO-1 signal was detected at intercellular junctions 5 days after the initiation of culture maintained under static conditions (Fig 4A) . Cultures of RBEC maintained under static conditions exhibited discontinues and/or patchy loss of tight junctions, as assessed by ZO-1 staining. By contrast, ZO-1 expression was more uniform and continuous when RBEC were cultured under flow conditions in B 3 C (Fig 4B) . Furthermore, the ZO-1 expression was uniform and markedly enhanced when RBEC were cultured under flow in the presence of ACM as shown in Fig 4C. Another important characteristic of a functional in vitro BBB is the ability of the astrocytes to exert brain (i.e. astrocytic) function on the endothelium. Thus, we co-cultured rat astrocytes (from passage 2) with RBEC (from passage 3) in our B 3 C model, the result of which are shown in Fig 4D through 4F. Fig 4D shows the bright field image of the co-culture of RBEC under shear flow in the vascular channel and astrocytes in the tissue compartment under static conditions. Fig 4E shows the immunofluorescence staining of RBEC and astrocytes in the co-culture B 3 C model. Similar to RBEC cultured in the presence of ACM (Fig 4C) , stronger expression of ZO-1 was observed at the intercellular junctions of RBEC when co-cultured with astrocytes ( Fig 4E) . To confirm the presence of GFAP expression in rat neonatal astrocytes grown in the tissue compartment of B 3 C we stained these cells with antibody against GFAP five days following seeding (Fig 4E) . RBEC and astrocyte nuclei were counterstained with Hoechst 33342 nuclear stain. Fig 4F shows Barrier formation by the brain endothelium is facilitated by the presence of glial cells, such as astrocytes, and the factors secreted by astrocytes [19, 20] . In addition to assessing tight junction formation as described above, permeability of tracers such as dextran can be used to quantify the tightness of the barrier formed by RBEC in B 3 C model. Using the B 3 C model we observed that barrier permeability was dependent on the presence of astrocytes or ACM. Significant reduction of passage of Texas Red 40 kDa dextran from the vascular channel to tissue compartment was observed when RBEC (from passage 3) were cultured under flow (0.01 μl/min, i.e. shear stress of 3.8x10 −3 dynes/cm 2 ) in the vascular channels in the presence of ACM or astrocytes (from passage 2) cultured in tissue compartment (Fig 5C and 5D , respectively) as compared to RBEC alone (Fig 5B) or cell-free device (Fig 5A) . Flow rate used for permeability experiments was 0.2 μl/min (i.e. shear stress of 7.6x10 -2 dynes/cm 2 ). As shown in Fig 5E, permeability of 40 kDa dextran in B 3 C cultured with RBC alone (41.0±0.9 x 10 −6 cm/s) was and when RBC were co-cultured with astrocytes (2.9±1.0 x 10 −6 cm/s).
In the vasculature of the brain and other tissues in vivo, permeability is reported to be heterogeneous along the length of a vessel [35] [36] [37] . Coefficient of variance for the measured intensities of fluorescent dextran at 12 regularly spaced regions of interest (ROIs) in the tissue compartment immediately adjacent to the vascular channel at 60 min after the initiation of the flow was used to assess the heterogeneity of permeability along the vascular channel in B 3 C (Fig 5F) . As expected, variability in permeation was lowest in cell-free B 3 C due to the uniform structure of the wall of the vascular channels. However, while the overall permeability of B 3 C decreases with the inclusion of ACM or astrocytes in its microenvironment (Fig 5E) , the extravasation of dextran becomes more heterogeneous along the vascular channel (Fig 5F) . C closely approximates the neonatal in vivo BBB. In this study, we used RBEC isolated from neonatal rats to develop the novel neonatal BBB on a chip. To establish that this model indeed exhibits BBB structural and functional characteristics that are different from adult BBB, we also constructed B 3 C using RBEC from adult Sprague Dawley rats (from passage 4) and the barrier structure and function of the BBB formed by neonatal and adult RBEC in B 3 C were compared. As shown in Fig 8, neonatal RBEC alone ( Fig  8A) and in the presence of ACM (Fig 8B) exhibit weaker and less organized ZO-1 staining compared to both adult RBEC alone (Fig 8C) and adult RBEC in the presence of ACM ( Fig  8D) . Consistent with results presented in Figs 5 and 6 , culturing neonatal RBEC with ACM in B 3 C improves barrier properties as indicated by the stronger ZO-1 staining (discontinuous weak granular ZO-1 staining in Fig 8A compared to discontinuous but stronger band-like ZO-1 staining in Fig 8B) . On the other hand, culturing adult RBEC with ACM in B 3 C does not significantly improve barrier properties as indicated by ZO-1 staining (similar continuous ZO-1 staining in both Fig 8C and 8D) . Furthermore, presence of ACM in B 3 C decreases permeability of 40 kDa dextran (Fig 8E) and increases electrical resistance (Fig 8F) more significantly in neonatal RBEC as compared to adult RBEC.
Discussion
In vitro BBB models that closely mimic the in vivo BBB microenvironment are valuable tools for the study of neonatal BBB function as well as for screening of novel therapeutics. Transwell BBB models approximate several of the important aspects of the in vivo BBB and are routinely used for BBB studies and for screening neurotherapeutics [38, 39] . More recently, dynamic flow-based in vitro BBB models have also been developed to better reproduce the in vivo microvascular environment [17, 18, 40, 41] . However, existing in vitro BBB models have a number of important limitations and for the most part do not mimic the microenvironment of the neonatal BBB. For example, while the DIV-BBB and NDIV-BBB models developed by Cucullo et al. represent a significantly improved design of in vitro BBB models, they still do not accurately represent the brain microvascular dimensions and geometry [17, 18, 40, 41] . Furthermore, Neonatal Blood-Brain Barrier on a Chip development of suitable in vitro BBB models of neonatal BBB is particularly important since there are significant differences in structure and function of neonatal and adult BBB [7, [26] [27] [28] . Having a relevant in vitro model of neonatal BBB is important for understanding neonatal neural pathogenesis and for developing appropriate treatment strategies.
This study demonstrates, for the first time, an in vitro neonatal BBB model that shows a significant improvement from the traditional transwell model and is able to mimic the in vivo brain microenvironmental conditions (e.g. shear flow and presence of glial cells). In order to develop and characterize an in vitro model of neonatal BBB, we designed a neonatal BBB on a chip (B 3 C) model for the co-culture of primary neonatal brain endothelial cells and neonatal astrocytes. In contrast to other microfluidic systems, the B 3 C design includes a tissue compartment enclosed by vascular channels. The tissue compartment and vascular channels are in communication via an interface with 3 μm pores along the length of the vascular channels, replacing the use of membranes in conventional BBB models. The three-dimensional geometry of vascular channels in B 3 C addresses the important challenge of developing in vitro BBB models with shear flow conditions which have been shown to be critical in the formation of realistically tight barriers [17, 21] . Furthermore, the optically clear microfluidic chip, and the architecture of the device, allows for visualization and real-time measurements of the dynamic interactions occurring in vascular channels and tissue compartment. As shown in Fig 3, neonatal rat brain microvascular endothelial cells (RBEC), grown on the fibronectin coated inner surfaces of vascular channels of the B 3 C form the endothelial lining along vascular channels with a complete lumen, thus mimicking the tubular morphology of the in vivo microvessels. The ability to reproduce the tubular morphology of the in vivo microvessels represents a significant advancement in our efforts to model the in vivo BBB. Furthermore, the ability to visualize the dynamic processes in the neonatal B 3 C model in real time is a significant advantage as compared to flow based hollow fiber dynamic BBB models and other membrane based microfluidic approaches [17, 18, 24, 25, 40, 41] . Thus, B 3 C offers a far more realistic representation of the in vivo BBB microenvironment compared to currently available in vitro BBB models [17-23, 40, 41] . In addition to allowing for real-time analysis in an in vivo like microenvironment, the B 3 C has the advantage of using significantly less of the often required expensive reagents compared to the currently available in vitro BBB models.
The endothelium of the in vivo BBB is continuously exposed to both physical stimuli (e.g. shear stress) and cellular signals (e.g. presence of perivascular cells). Certain features of the BBB, for example the size and geometry of the microvessels in the brain, define the shear stress and flow patterns occurring at the in vivo BBB and contribute to the biochemical and functional characteristics of the BBB [1, 17, 21] . Thus, for a truly functional and physiologically realistic in vitro BBB, it is essential to incorporate the in vivo flow characteristics in the design of an in vitro BBB model. Accordingly, the neonatal B Fig 4B) compared to RBEC cultured under static conditions (Fig 4A) .
Moreover, the neonatal B 3 C model was developed with a co-culture of astrocytes, which are known to contribute to the regulation and maintenance of BBB homeostasis, integrity and function [1, 18, [42] [43] [44] [45] [46] [47] . We observed the functional improvement of the BBB in the neonatal B C the barrier properties of neonatal RBEC are significantly different from that of adult RBEC. We also observed astrocyte protrusions and/or endfeet (indicated by the GFAP and nuclear staining in Fig 4F) through the 3 μm porous interface between the tissue and vascular compartments suggesting that the design of B 3 C allows physical and biochemical communication between the RBEC cultured in the vascular channel and the astrocytes cultured in the tissue compartment, which is essential for the formation of tighter BBB. Previously, a double monolayer formation of endothelial cells was observed in large pore sized (3 μm and upwards) transwell inserts due to endothelial cell migration through the insert pores [48] . In B C, the endothelial migration from vascular channel to the tissue compartment is further reduced as can be seen in Fig 4E and 4F (also S2 Fig) .
Growing evidence suggests that flow based in vitro BBB models exhibit improved performance and better approximate the in vivo BBB as compared to transwell based BBB models [17, 18, 21-23, 40, 41] . Consistent with these observations, the permeability of our microfluidic neonatal blood-brain barrier (B 3 C) model was found to be significantly lower than that of the transwell BBB model (Fig 7) . Furthermore, as shown in Fig 7, the permeability of B 3 C model approximates the permeability of neonatal rat BBB in vivo supporting the notion that this system mimics many structural and functional characteristics of the in vivo BBB system. In summary, we developed a dynamic neonatal BBB on a chip ( 
